<div style=

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (5686 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Guide

Abstract Objective:To explore the potential mechanism of Astragalus membranaceus and Atractylodes macrocephala in the treatment of osteoporotic fracture (OPF) based on network pharmacology. Methods: The active components and action targets of Astragalus membranaceus and Atractylodes macrocephala were screened by pharmacologic database and Analysis Platform (TCMSP) . GeneCards, OMIM and TTD databases related to disease targets were retrieved to screen the action targets of OPF, and then the intersection core targets of Astragalus membranaceus, Atractylodes macrocephala membranaceus and OPF were screened. Cytoscape 3.7.1 software was used to construct a compoundtargetdisease network, and DAVID database was used to analyze the enrichment of GO function and KEGG pathway. Results: Based on TCMSP database, 19 active components and 115 intersection targets of Astragalus membranaceus-Atractylodes for OPF were screened. A total of 568 items were obtained by GO functional enrichment analysis, including 433 biological process items, 43 cell composition items and 92 molecular function items. KEGG pathway enrichment analysis revealed 111 items, including AGE-RAGE, IL-17, TNF, prostate cancer, Toll-like receptor, HIF-1, NF-κB signaling pathway, etc. Conclusion: Astragalus membranaceus and Atelectylodes atelectylodes may regulate inflammatory response and internal balance of osteoclasts by regulating TNF, NF-κB and HIF-1 signaling pathways, and thus exert therapeutic actions on OPF.

Key words：

Received: 10 September 2021

Fund:

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MAO Yinfeng
	CUI Songxiang
	HUA Zhen
	PENG Hongcheng
	WANG Jianwei

Cite this article:

MAO Yinfeng,CUI Songxiang,HUA Zhen等.

Network pharmacology of Astragalus membranaceusAtractylodes macrocephala in the treatment of osteoporotic fractures

[J]. Journal of Jiangsu University(Medicine Edition), 2022, 22(1): 13-17.

URL:

http://zzs.ujs.edu.cn/xbyxb/EN/ OR http://zzs.ujs.edu.cn/xbyxb/EN/Y2022/V22/I1/13

［1］白璧辉, 谢兴文, 李鼎鹏, 等.我国近5年来骨质疏松症流行病学研究现状［J］.中国骨质疏松杂志, 2018, 24(2): 253-258.

［2］Hollensteiner M, Sandriesser S, Bliven E, et al. Biomechanics of osteoporotic fracture fixation［J］. Curr Osteoporos Rep, 2019, 17(6): 363-374.

［3］于海洋,王志勇,汪海燕,等.基于“肠道微生态”谈中医学从“脾”论治骨质疏松症的科学内涵［J］.中国骨质疏松杂志, 2021, 27(3): 459-462,468.

［4］马江,涛黄红,万雷,等.骨碎补治疗骨质疏松性骨折的网络药理学研究［J］.中华中医药学刊, 2020, 38(7): 89-92.

［5］Liu JF, Hu AN, Zan JF, et al. Network pharmacology deciphering mechanisms of volatiles of wendan granule for the treatment of alzheimer′s disease［J］. Evid Based Complement Alternat Med, 2019, 2019: 1-12.

［6］汤菲菲,梁鹏晨,石涵芬,等.基于网络药理学和分子对接探讨凉血消斑汤治疗寻常型银屑病的作用机制［J］.江苏大学学报(医学版), 2021, 31(3): 257-263.

［7］李晶峰,李春楠,杨小倩,等.基于网络药理学对龟甲抗骨质疏松的作用机制研究［J］.中国骨质疏松杂志, 2020, 26(12): 1760-1767.

［8］Wong SK, Chin KY, ImaNirwana S. Quercetin as an agent for protecting the bone:a review of the current evidence［J］. Int J Mol Sci, 2020, 21(17): 6448.

［9］Kong X, Wang F, Niu Y, et al. A comparative study on the effect of promoting the osteogenic function of osteoblasts using isoflavones from radix astragalus［J］. Phytother Res, 2018, 32(1): 115-124.

［10］洪一波,姜宏,王建伟,等.芒柄花素抑制RANKL诱导破骨细胞分化的实验研究［J］.中国骨伤, 2020, 33(1): 64-70.

［11］Wong SK, Chin KY, ImaNirwana S. The osteoprotective effects of kaempferol: the evidence from in vivo and in vitro studies ［J］. Drug Des Devel Ther, 2019, 13: 3497-3514.

［12］赵希云,张晓刚,曹林忠,等.从脾肾论治骨质疏松症的OPG/RANK/RANKL信号调控机制［J］.中国骨质疏松杂志, 2016, 22(9): 1206-1210.

［13］Lin TH, Pajarinen J, Lu L, et al.NF-κB as a thera-peutic target in inflammatoryassociated bone diseases［J］. Adv Protein Chem Struct Biol, 2017, 107: 117-154.

［14］Zhao B.TNF and bone remodeling.［J］. Curr Osteoporos Rep, 2017, 15(3): 126-134.

［15］梁祖建,庄洪,刘忠厚,等.青壮年骨折与骨质疏松性骨折愈合机理及药物促愈机制研究进展［J］.中国骨质疏松杂志, 2009, 15(9): 697-702.

［16］Yang T, Martin P, Fogarty B, et al. Exosome delivered anticancer drugs across the bloodbrain barrier for brain cancer therapy in Daniorerio［J］. Pharm Res, 2015, 32(6): 2003-2014.

［17］AlonsoPérez A, FrancoTrepat E, GuillánFresco M, et al. Role of tolllike receptor 4 on osteoblast metabolism and function［J］. Front Physiol, 2018, 9: 504

［18］Le Goff B, Bouvard B, Lequerre T, et al. Implication of IL17 in bone loss and structural damage in inflammatory rheumatic diseases［J］. Mediators Inflamm, 2019, 2019: 1-9.

［19］李乐飞,杨静,王佩婷,等.HIF1在骨修复及骨再生中作用的研究进展［J］.武警后勤学院学报(医学版), 2016, 25(5): 414-417.